CIK 0001228627
- Non-accelerated filer
- Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113516358
- Phone
- +1 984-884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- 4 Grant or award Director acquired 10,976 shares (grant or award)
- 4 Grant or award Director acquired 10,976 shares (grant or award)
- 4 Grant or award Director acquired 10,976 shares (grant or award)
- 4 Grant or award Director acquired 10,976 shares (grant or award)
- 4 Grant or award Director acquired 10,976 shares (grant or award)
- 4 Grant or award SVP, Operations & Bus. Dev. acquired 20,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 2,819 shares (grant or award)
- 4 Grant or award Director acquired 1,053 shares (grant or award)
- 4 Grant or award Interim CEO and President acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 468 shares (grant or award)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Grant or award President and CEO acquired 134,456 shares (grant or award)
- 4 Grant or award Director acquired 18,544 shares (grant or award)
- 4 Grant or award Director acquired 13,013 shares (grant or award)
- 4 Grant or award Director acquired 20,822 shares (grant or award)
- 4 Grant or award SVP of Corp. Dev. & Ops & Sec. acquired 46,608 shares (grant or award)
- 4 Grant or award SVP of Finance acquired 46,608 shares (grant or award)
- 4 Grant or award Director acquired 16,267 shares (grant or award)
Page 7 of 21 · 403 filings